Patents by Inventor Emil Richard George Pot

Emil Richard George Pot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of immune diseases by administration of antigen-specific formulations
    Patent number: 11918683
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Grant
    Filed: December 1, 2022
    Date of Patent: March 5, 2024
    Assignee: Allero Therapeutics B.V.
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen
  • TREATMENT OF IMMUNE DISEASES BY ADMINISTRATION OF ANTIGEN-SPECIFIC FORMULATIONS
    Publication number: 20230149305
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Application
    Filed: December 1, 2022
    Publication date: May 18, 2023
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen
  • Treatment of immune diseases by administration of antigen-specific formulations
    Patent number: 11547662
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: January 10, 2023
    Assignee: Allero Therapeutics B.V.
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen
  • TREATMENT OF IMMUNE DISEASES BY ADMINISTRATION OF ANTIGEN-SPECIFIC FORMULATIONS
    Publication number: 20210030664
    Abstract: The present invention relates to the treatment of autoimmune and allergic diseases by oromucosal administration of a formulation consisting of an optimized combination of antigen, tolerizing agent and mucoadhesive carrier for each immune disease indication.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 4, 2021
    Applicant: Allero Therapeutics B.V.
    Inventors: Emil Richard George Pot, Cornelis Johannes Leenhouts, Poul Sörensen